Annual Cash & Cash Equivalents
$13.67 M
-$4.94 M-26.56%
December 31, 2022
Summary
- As of February 9, 2025, TALS annual cash & cash equivalents is $13.67 million, with the most recent change of -$4.94 million (-26.56%) on December 31, 2022.
- During the last 3 years, TALS annual cash & cash equivalents has fallen by -$25.31 million (-64.93%).
Performance
TALS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$18.35 M
-$5.87 M-24.24%
June 30, 2023
Summary
- As of February 9, 2025, TALS quarterly cash and cash equivalents is $18.35 million, with the most recent change of -$5.87 million (-24.24%) on June 30, 2023.
- Over the past year, TALS quarterly cash and cash equivalents has dropped by -$7.17 million (-28.09%).
Performance
TALS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TALS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.6% | -28.1% |
| 3 y3 years | -64.9% | - |
| 5 y5 years | -64.9% | - |
TALS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.6% | at low | -28.1% | -25.5% |
| 5 y | 5-year | -64.9% | at low | -49.4% | -46.1% |
| alltime | all time | -64.9% | at low | -49.4% | -46.1% |
Talaris Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $18.35 M(-24.2%) |
| Mar 2023 | - | $24.22 M(+77.2%) |
| Dec 2022 | $13.67 M(-26.6%) | $13.67 M(-26.0%) |
| Sep 2022 | - | $18.47 M(-27.6%) |
| Jun 2022 | - | $25.52 M(+12.0%) |
| Mar 2022 | - | $22.79 M(+22.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $18.61 M(+5.8%) | $18.61 M(-31.8%) |
| Sep 2021 | - | $27.31 M(-24.8%) |
| Jun 2021 | - | $36.30 M(+267.0%) |
| Mar 2021 | - | $9.89 M(-43.8%) |
| Dec 2020 | $17.59 M(-54.9%) | - |
| Dec 2020 | - | $17.59 M |
| Dec 2019 | $38.98 M | - |
FAQ
- What is Talaris Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Talaris Therapeutics?
- What is Talaris Therapeutics annual cash & cash equivalents year-on-year change?
- What is Talaris Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Talaris Therapeutics?
- What is Talaris Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Talaris Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of TALS is $13.67 M
What is the all time high annual cash & cash equivalents for Talaris Therapeutics?
Talaris Therapeutics all-time high annual cash & cash equivalents is $38.98 M
What is Talaris Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, TALS annual cash & cash equivalents has changed by -$4.94 M (-26.56%)
What is Talaris Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TALS is $18.35 M
What is the all time high quarterly cash and cash equivalents for Talaris Therapeutics?
Talaris Therapeutics all-time high quarterly cash and cash equivalents is $36.30 M
What is Talaris Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, TALS quarterly cash and cash equivalents has changed by -$7.17 M (-28.09%)